Cyclerion Therapeutics CYCN
NASDAQ CYCN
$3.91 -0.16 (-4.03%)
As of: Aug 21, 2026 · 3:11 PM EDT

Cyclerion Therapeutics (CYCN) Operating Margin (QoQ) (2019 - 2025)

Cyclerion Therapeutics (CYCN) Operating Margin (QoQ) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.54 Bn 130.69 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.89 Bn 77.89 Bn 3.93 Bn
3 Argenx Se 64.84 Bn 59.65 Bn 1.37 Bn
4 Moderna 56.53 Bn 51.39 Bn 52.00 Mn
5 BeOne Medicines 41.97 Bn 36.87 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.53 Bn 28.22 Bn 992.69 Mn
7 BioNTech SE 27.70 Bn 9.31 Bn 668.28 Mn
8 Insmed 27.45 Bn 26.29 Bn 358.27 Mn
9 Royalty Pharma 27.33 Bn 26.49 Bn -
10 Cyclerion Therapeutics 12.29 Mn 9.05 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 168,288.00
Jun 30, 2025 92.00
Mar 31, 2025 -182,656.00
Dec 31, 2024 60,924.00
Jun 30, 2022 -256,371.00
Mar 31, 2022 86,390.00
Dec 31, 2021 55,276.00
Sep 30, 2021 -270,362.00
Jun 30, 2021 2.11 Mn
Mar 31, 2021 -715,070.00
Dec 31, 2020 -900,914.00
Sep 30, 2020 -281,856.00
Jun 30, 2020 -59,596.00
Mar 31, 2020 -23,533.00
Dec 31, 2019 20,887.00
Sep 30, 2019 2,634.00